Evidence map›Paper›PMID 29780003›Full record

ArticleMolecular metabolism2018

A disease-associated Aifm1 variant induces severe myopathy in knockin mice.

Lena Wischhof, Anna Gioran, Dagmar Sonntag-Bensch, Antonia Piazzesi, Miriam Stork, Pierluigi Nicotera, Daniele Bano

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. AIF3 splicing switch triggers neurodegeneration.Molecular neurodegeneration · 2021
    Article
  19. Regulation of diurnal energy balance by mitokines.Cellular and molecular life sciences : CMLS · 2021
    Review
  20. Alopecia in Harlequin mutant mice is associated with reduced AIF protein levels and expression of retroviral elements.Mammalian genome : official journal of the International Mammalian Genome Society · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Lena WischhofGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Anna GioranGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Dagmar Sonntag-BenschGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Antonia PiazzesiGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Miriam StorkGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Pierluigi NicoteraGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Daniele BanoGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. Electronic address: daniele.bano@dzne.de.
German Center for Neurodegenerative Diseases · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMutations in the AIFM1 gene have been identified in recessive X-linked mitochondrial diseases. Functional and molecular consequences of these pathogenic AIFM1 mutations have been poorly studied in vivo. METHODS/

resultsHere we provide evidence that the disease-associated apoptosis-inducing factor (AIF) deletion arginine 201 (R200 in rodents) causes pathology in knockin mice. Within a few months, posttranslational loss of the mutant AIF protein induces severe myopathy associated with a lower number of cytochrome c oxidase-positive muscle fibers. At a later stage, Aifm1 (R200 del) knockin mice manifest peripheral neuropathy, but they do not show neurodegenerative processes in the cerebellum, as observed in age-matched hypomorphic Harlequin (Hq) mutant mice. Quantitative proteomic and biochemical data highlight common molecular signatures of mitochondrial diseases, including aberrant folate-driven one-carbon metabolism and sustained Akt/mTOR signaling.

conclusionOur findings indicate metabolic defects and distinct tissue-specific vulnerability due to a disease-causing AIFM1 mutation, with many pathological hallmarks that resemble those seen in patients.

Indexed as

AnimalsApoptosis Inducing FactorGene Knock-In TechniquesMiceMitochondriaMitochondrial DiseasesMuscle Fibers, SkeletalMuscular DiseasesMutationPeripheral Nervous System DiseasesProteomicsAIFM1 protein, humanApoptosis Inducing Factor1C metabolismAkt/mTOR signalingApoptosis-inducing factor (AIF)MitochondriaMitochondrial diseasesOxidative phosphorylation

Identifiers

PMID29780003
PMCPMC6026322
OpenAlexW2802801856

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.